MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Veledimex racemate

CAS No. : 755013-59-3

MCE 站：Veledimex racemate

产品活性：Veledimex racemate (INXN-1001 racemate) 是 Veledimex 的外消旋体。Veledimex 是 RheoSwitch 系统中有口服活性的小分子激活剂配体。

研究领域：Immunology/Inflammation  |  Metabolic Enzyme/Protease

作用靶点：Interleukin Related  |  Cytochrome P450

In Vitro: Interleukin 12 (IL-12) is a pro-inflammatory cytokine critical for stimulating anti-cancer immune responses. Ad-RTS-IL-12 is the adenovirusvector engineered to express hIL-12. Veledimex is an orally active small-molecule diacylhydrazine and controls the expression of the target gene. The amount of gene product produced by the system and the duration of the effect are dependent on veledimex dose level and duration of dosing.

In Vivo: Veledimex, combined with Ad-RTS-hIL-12, is in phase I/II clinical trials for the treatment of melanoma and breast cancer. Intratumoral administration of Ad-RTS-mIL-12 along with oral administration of veledimex elicits dose-dependent antitumor effects in murine melanoma, breast cancer, and glioma models, which correlates with increased plasma exposure of veledimex. The increase in tumor veledimex levels in combination with Ad-RTS-mIL-12 results in a dose-related increase in the IL-12 mRNA (switch on) leading to dose-related increases in IL-12p70 in the tumor with minimal increase in serum IL-12. The increase in tumor IL-12 correlates with an increase in tumor CD8+ cytotoxic T cells and a concomitant decrease in regulatory T cells in the tumor microenvironment, which leads to Ad-RTS-mIL-12 + veledimex–elicited dose-related decreases in tumor growth rate with no significant change in body weight in both breast and melanoma syngeneic mouse models. Veledimex has moderate to low oral bioavailability after a single oral administration in mice and monkeys (-56% in mice and up to 17.4% in cynomolgus monkeys) with mostly low plasma clearance (1399 and 1170 mL/h per kilogram in mice and monkeys, respectively), high volume of distribution (20271 and 9180 mL/h per kilogram in mice and monkeys, respectively), and long terminal half-lives (-10 hours in mice and -30 hours in monkeys) after intravenous administration.

相关产品：Resatorvid  |  Disulfiram  |  Verapamil hydrochloride  |  Apigenin  |  Fenofibrate  |  Tocilizumab  |  Ketoconazole  |  1-Aminobenzotriazole  |  Itraconazole  |  Abiraterone  |  Talarozole  |  Clarithromycin  |  Atazanavir sulfate  |  Isavuconazole  |  Atovaquone  |  Memantine hydrochloride  |  Diacerein  |  Galangin  |  Naringin  |  Metyrapone  |  Furafylline  |  Gemfibrozil  |  Vidofludimus  |  Fomepizole  |  LMT-28  |  Muscone  |  Diosmetin  |  SC144  |  Hydrocortisone hemisuccinate

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。